Windtree shareholders approve 2020 equity plan amendment adding 645,000 shares

WINDTREE THERAPEUTICS INC /DE/

Amendment to 2020 Plan increases authorized shares by 645,000 to 738,175 total shares.
Evergreen provision removed; share recycling prohibited; one-year minimum vesting imposed; dividends on unvested awards banned.
All five director nominees elected: Craig E. Fraser, Daniel Geffken, Robert Scott, Mark Strobeck, Leslie J. Williams.
Advisory vote on executive compensation passed: 666,480 for, 86,688 against, 9,587 abstentions (87.4% of votes cast).
Ratification of EisnerAmper LLP as independent auditor for 2023 approved: 2,120,083 for, 48,301 against, 74,426 abstentions.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ shareholders approved Ratification of Appointment of EisnerAmper LLP as the Company's Independent Registered Public Accounting Firm for 2023 at the 2023-08-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-08-15

Exact text from the filing

The votes with respect to the ratification of appointment of EisnerAmper LLP as the Company's Independent Registered Public Accounting Firm for 2023 were as follows: Votes For Votes Against Abstentions Broker Non-Votes 2,120,083 48,301 74,426 N/A

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ shareholders approved Election of the Five Director Nominees to Serve until the Company's 2024 Annual Meeting at the 2023-08-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-08-15

Exact text from the filing

The votes with respect to the election of five directors to hold office until the 2024 annual meeting were as follows: Director Votes For Votes Withheld Broker Non-Votes Craig E. Fraser 740,143 22,612 1,480,055 Daniel Geffken 728,246 34,509 1,480,055 Robert Scott, M.D. 591,638 171,117 1,480,055 Mark Strobeck, Ph.D. 729,893 32,862 1,480,055 Leslie J. Williams 567,849 194,906 1,480,055

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ shareholders approved Approval of the Amended and Restated Windtree Therapeutics 2020 Equity Incentive Plan at the 2023-08-15 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-08-15

Exact text from the filing

The votes with respect to the approval of the Amended and Restated Windtree Therapeutics 2020 Equity Incentive Plan were as follows: Votes For Votes Against Abstentions Broker Non-Votes 669,259 88,539 4,957 1,480,055

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers at the 2023-08-15 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-08-15

Exact text from the filing

The votes with respect to the approval, on an advisory basis, of the compensation of the Company's named executive officers were as follows: Votes For Votes Against Abstentions Broker Non-Votes 666,480 86,688 9,587 1,480,055

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-23-023974

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.